Evotec SE — Director's Dealing 2023

Jan 20, 2023

News Details

Directors’ Dealings | 20 January 2023 16:40

Evotec SE: Dr. Werner Lanthaler, Exercise against cash settlement (Share Performance Plan)

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

20.01.2023 / 16:39 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Dr.
First name:	Werner
Last name(s):	Lanthaler

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Evotec SE

b) LEI

529900F9KI6OYITO9B12

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE0005664809

b) Nature of the transaction

Exercise against cash settlement (Share Performance Plan)
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)

Price(s)	Volume(s)
17.9445 EUR	468,010.50 EUR

d) Aggregated information

Price	Aggregated volume
17.9445 EUR	468,010.50 EUR

e) Date of the transaction

2023-01-19; UTC+1

f) Place of the transaction

Outside a trading venue

---

20.01.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Evotec SE
	Manfred Eigen Campus / Essener Bogen 7
	22419 Hamburg
	Germany
Internet:	www.evotec.com

End of News	EQS News Service